The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 241 | 14,899 | SH | SOLE | 14,899 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 236 | 5,115 | SH | SOLE | 5,115 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,021 | 10,487 | SH | SOLE | 10,487 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 1,039 | 14,255 | SH | SOLE | 14,255 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 328 | 1,685 | SH | SOLE | 1,685 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 826 | 9,698 | SH | SOLE | 9,698 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 320 | 1,062 | SH | SOLE | 1,062 | 0 | 0 | ||
BIO TECHNE CORP | COM | 09073M104 | 255 | 1,762 | SH | SOLE | 1,762 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 271 | 2,734 | SH | SOLE | 2,734 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 640 | 9,983 | SH | SOLE | 9,983 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 302 | 2,665 | SH | SOLE | 2,665 | 0 | 0 | ||
CHECKPOINT THERAPEUTICS INC | COM | 162828107 | 205 | 112,760 | SH | SOLE | 112,760 | 0 | 0 | ||
DIREXION SHS ETF TR | SP BIOTCH BL NEW | 25490K323 | 2,277 | 69,309 | SH | SOLE | 69,309 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 426 | 21,646 | SH | SOLE | 21,646 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 310 | 6,691 | SH | SOLE | 6,691 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 34960Q109 | 201 | 234,030 | SH | SOLE | 234,030 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 289 | 4,618 | SH | SOLE | 4,618 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 315 | 17,176 | SH | SOLE | 17,176 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 1,472 | 4,908 | SH | SOLE | 4,908 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 776 | 12,205 | SH | SOLE | 12,205 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 356 | 3,534 | SH | SOLE | 3,534 | 0 | 0 | ||
INTREXON CORP | COM | 46122T102 | 177 | 27,109 | SH | SOLE | 27,109 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 1,206 | 22,307 | SH | SOLE | 22,307 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 307 | 2,643 | SH | SOLE | 2,643 | 0 | 0 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | 12,054 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | 8,197 | 85,000 | SH | Call | SOLE | 85,000 | 0 | 0 | |
LOXO ONCOLOGY INC | COM | 548862101 | 870 | 6,210 | SH | SOLE | 6,210 | 0 | 0 | ||
METTLER TOLEDO INTERNATIONAL | COM | 592688105 | 1,830 | 3,235 | SH | SOLE | 3,235 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 435 | 13,223 | SH | SOLE | 13,223 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 213 | 2,986 | SH | SOLE | 2,986 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 484 | 11,250 | SH | SOLE | 11,250 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 81 | 11,353 | SH | SOLE | 11,353 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 940 | 2,516 | SH | SOLE | 2,516 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 1,084 | 19,127 | SH | SOLE | 19,127 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 232 | 5,339 | SH | SOLE | 5,339 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 290 | 2,664 | SH | SOLE | 2,664 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,436 | 8,664 | SH | SOLE | 8,664 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 224 | 7,605 | SH | SOLE | 7,605 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 2,185 | 138,461 | SH | SOLE | 138,461 | 0 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 1,084 | 31,463 | SH | SOLE | 31,463 | 0 | 0 |